Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in Pediatric Onset Multiple Sclerosis: Research of Biomarkers Predictive of Cognitive Impairment Progression

NCT03190902 is registered in ClinicalTrials.gov with Pietro Iaffaldano as lead sponsor.

NCT NCT03190902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03190902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in Pediatric Onset Multiple Sclerosis: Research of Biomarkers Predictive of Cognitive Impairment Progression
Lead sponsor
Pietro Iaffaldano
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2015
Completion date
April 30, 2016
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adhd predominantly inattentive type, pediatric onset multiple sclerosis